SCHEMBL2335374

SCHEMBL2335374

CC(C)[C@@H](C)N(CCCc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS5 Q9UNA0 2/20 0.52
ALDH1A1 P00352 2/20 0.48
TP53 P04637 1/20 0.48
GAA P10253 1/20 0.48
PSEN1 P49768 5/20 0.47
PSEN2 P49810 5/20 0.47
APH1B Q8WW43 5/20 0.47
NCSTN Q92542 5/20 0.47
APH1A Q96BI3 5/20 0.47
PSENEN Q9NZ42 5/20 0.47
POLB P06746 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CNR2 P34972 2/20 0.45
CNR1 P21554 1/20 0.45
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
BACE1 P56817 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2335370 1.00 ADAMTS5 (0.52) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2332910 0.86 ADAMTS5 (0.51) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2332915 0.86 ADAMTS5 (0.51) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2335682 0.85 ADAMTS5 (0.50) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2337938 0.85 PSEN1 (0.55) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2335609 0.84 ADAMTS5 (0.49) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2332243 0.83 ADAMTS5 (0.48) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2335348 0.81 ADAMTS5 (0.49) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2333175 0.81 ADAMTS5 (0.49) ADAMTS5ALDH1A1TP53GAAPSEN1
SCHEMBL2336537 0.81 PSEN1 (0.51) ADAMTS5ALDH1A1TP53GAAPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120270902-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2012-10-25 US claimed
EP-2374792-A1 N-substituted benzene sulfonamides Elan Pharmaceuticals Inc. (US) 2011-10-12 EP claimed
US-20050245573-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. 2005-11-03 US claimed
US-20120270902-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2012-10-25 US disclosed
US-8193389-B2 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. (US) 2012-06-05 US disclosed
EP-2374792-A1 N-substituted benzene sulfonamides Elan Pharmaceuticals Inc. (US) 2011-10-12 EP disclosed
EP-2360142-A1 N-substituted benzene sulfonamides Elan Pharmaceuticals Inc. (US) 2011-08-24 EP disclosed
US-20050245573-A1 N-substituted benzene sulfonamides ELAN PHARMACEUTICALS, INC. 2005-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245573-A1 N-substituted benzene sulfonamides PSEN1, PSEN2, BCHE ADAMTS5 4395/4885ALDH1A1 665/4885TP53 224/4885
US-20120270902-A1 N-substituted benzene sulfonamides PSEN1, PSEN2, BCHE ADAMTS5 4395/4885ALDH1A1 665/4885TP53 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.